Clincosm LogoSign in Get a demo

Essential Hypertension

Showing 51 - 75 of 213
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Essential Hypertension, Hypercholesterolemia Trial (Perindopril/Amlodipine and Perindopril/Amlodipine/Atorvastatin treatment)

Unknown status
  • Essential Hypertension
  • Hypercholesterolemia
  • Perindopril/Amlodipine and Perindopril/Amlodipine/Atorvastatin treatment
  • (no location specified)
Mar 10, 2020

Essential Hypertension, Atrial Fibrillation Trial in Montreal (Perindopril)

Completed
  • Essential Hypertension
  • Atrial Fibrillation
  • Montreal, Quebec, Canada
    Montreal Heart Institute
Feb 20, 2020

Essential Hypertension Trial in Osaka (CS-3150, , eplerenone)

Completed
  • Essential Hypertension
  • Osaka, Japan
    (unnamed)
Oct 4, 2019

Essential Hypertension Trial in Osaka (CS-3150)

Completed
  • Essential Hypertension
  • Osaka, Japan
    (unnamed)
Oct 4, 2019

Cardiovascular Disease, Essential Hypertension, Nicotine Dependence Trial in Seattle (Coaching, Educational Outreach, Site

Completed
  • Cardiovascular Disease
  • +3 more
  • Coaching
  • +2 more
  • Seattle, Washington
    GroupHealthCoop
Sep 12, 2019

Essential Hypertension Trial in Beijing (remote ischemic conditioning, ambulatory blood pressure monitoring, Sham remote

Unknown status
  • Essential Hypertension
  • remote ischemic conditioning
  • +2 more
  • Beijing, Beijing, China
    Xuan Wu Hospital，Capital Medical University
Sep 11, 2019

Essential Hypertension, Dyslipidemia Trial in Seoul (Fimasartan/Amlodipine, Rosuvastatin, Fimasartan/Amlodipine, Fimasartan,

Completed
  • Essential Hypertension
  • Dyslipidemia
  • Fimasartan/Amlodipine, Rosuvastatin
  • +2 more
  • Seoul, Korea, Republic of
    Samsung Medical Center
Jun 7, 2019

Essential Hypertension Trial in Concepción (Transmedial Psychoeducational Program to improve adherence full or partial (PS))

Completed
  • Essential Hypertension
  • Transmedial Psychoeducational Program to improve adherence full or partial (PS)
  • Concepción, Chile
    Universidad de Concepción
May 2, 2019

Essential Hypertension, Vascular Diseases, Cardiovascular Diseases Trial in Chongqing (Renal nerve stimulation, mapping and

Unknown status
  • Essential Hypertension
  • +2 more
  • Renal nerve stimulation, mapping and denervation
  • Sham Procedure: Renal angiography
  • Chongqing, Chongqing, China
    2ndChongqingMU
Mar 22, 2019

Essential Hypertension Trial in Chongqing (renal sympathetic modification)

Unknown status
  • Essential Hypertension
  • renal sympathetic modification
  • Chongqing, Chongqing, China
    2ndChongqingMU
Mar 18, 2019

Essential Hypertension Trial in Seoul

Completed
Has Results
  • Essential Hypertension
    • Seoul, Korea, Republic of
      Yoon Jun Kim
    Feb 10, 2019

    Essential Hypertension Trial in China (Azilsartan medoxomil, Valsartan, Azilsartan medoxomil Placebo)

    Completed
    Has Results
    • Essential Hypertension
    • Azilsartan medoxomil
    • +3 more
    • Beijing, Beijing, China
    • +29 more
    Feb 15, 2019

    Essential Hypertension, Type 2 Diabetes Trial in China, Taiwan, Thailand (Azilsartan Medoxomil)

    Completed
    Has Results
    • Essential Hypertension
    • Type 2 Diabetes Mellitus
    • Azilsartan Medoxomil
    • Hong Kong, Hong Kong, China
    • +11 more
    Oct 29, 2018

    RAS Peptide Profiles in Patients With Arterial Hypertension

    Completed
    • Essential Hypertension
    • Basel, Switzerland
      University Hospital
    Feb 21, 2019

    Safety of Nebivolol in Korean Essential Hypertension

    Completed
    • Essential Hypertension
      • Incheon, Korea, Republic of
        Inha University Hospital
      Feb 19, 2019

      Essential Hypertension Trial in Bern (Syntocinon-Spray, Placebo of syntocinon, Social support)

      Terminated
      • Essential Hypertension
      • Bern, Switzerland
        Department of Psychology, University of Bern
      Jan 14, 2019

      Essential Hypertension Trial in Jaipur (Vedic Medical Astrology, Placebo vedic medical astrology (PMA))

      Completed
      • Essential Hypertension
      • Vedic Medical Astrology
      • Placebo vedic medical astrology (PMA)
      • Jaipur, Rajasthan, India
        NMP Medical Reserach Institute
      Jan 11, 2019

      Essential Hypertension Trial in Worldwide (Olmesartan medoxomil 40 mg - Amlodipine 10 mg, Olmesartan 40mg-Amlodipine

      Completed
      Has Results
      • Essential Hypertension
      • Olmesartan medoxomil 40 mg - Amlodipine 10 mg
      • +4 more
      • Graz, Austria
      • +116 more
      Dec 20, 2018

      Essential Hypertension Trial in Worldwide (olmesartan medoxomil + amlodipine + hydroclororthiazide + , Olmesartan medoxomil +

      Completed
      Has Results
      • Essential Hypertension
      • olmesartan medoxomil + amlodipine + hydroclororthiazide + placebo
      • +3 more
      • Antwerp, Belgium
      • +132 more
      Dec 20, 2018

      Essential Hypertension Trial in Worldwide (olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets, olmesartan medoxomil

      Completed
      Has Results
      • Essential Hypertension
      • olmesartan medoxomil (OM)+ hydrochlorothiazide (HCTZ) tablets
      • olmesartan medoxomil (OM)/ hydrochlorothiazide (HCTZ) 20mg/25mg
      • Brugge, Belgium
      • +40 more
      Dec 20, 2018

      Essential Hypertension Trial in Worldwide (olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets and , olmesartan

      Completed
      Has Results
      • Essential Hypertension
      • olmesartan medoxomil (OM)/hydrochlorothiazide (HCTZ) tablets and placebo
      • +2 more
      • Pleven, Bulgaria
      • +54 more
      Dec 20, 2018

      Essential Hypertension Trial in Germany (olmesartan medoxomil, amlodipine)

      Completed
      • Essential Hypertension
      • Hamburg, Germany
      • +5 more
      Dec 20, 2018

      Essential Hypertension Trial in Germany (olmesartan medoxomil, amlodipine, hydrochlorothiazide)

      Completed
      • Essential Hypertension
      • olmesartan medoxomil
      • +2 more
      • Leipzig, Germany
      • +4 more
      Dec 20, 2018

      Essential Hypertension Trial in Korea, Republic of (CS8635 20/5/12.5mg and , Olmetec® Plus 20/12.5mg and )

      Completed
      • Essential Hypertension
      • CS8635 20/5/12.5mg and placebo
      • Olmetec® Plus 20/12.5mg and placebo
      • Ansan, Korea, Republic of
      • +38 more
      Dec 20, 2018

      Essential Hypertension, Carotid Plaque Trial in Sesto Fiorentino (Atenolol, olmesartan medoxomil)

      Terminated
      • Essential Hypertension
      • Carotid Plaque
      • Sesto Fiorentino, Italy
        (unnamed)
      Dec 20, 2018